LTK	chr15	41,503,642	41,513,887	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the LTK gene on chr15 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
LYL1	chr19	13,099,027	13,103,160	NA	NA	NA	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T-ALL, 3 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the LYL1 gene on chr19 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
MAPK1	chr22	21,759,657	21,867,680	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the MAPK1 gene on chr22 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
MEF2D	chr1	156,463,727	156,500,779	minus	NA	B-ALL with MEF2D rearrangement (PMID: 36422706)	No	No	BCL9, HNRNPUL1	Translocation/rearranngement	FUS	ALL	1A for B-ALL, 2 for T-ALL	Optical Genome Mapping detected a [Translocation/rearranngement] mutation involving the MEF2D gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant is associated with a poor prognosis (PMID: 36422706).
MEN1	chr11	64,803,514	64,811,294	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the MEN1 gene on chr11 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
MSN	chrX	65,667,644	65,741,931	NA	NA	NA	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T-ALL, 3 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the MSN gene on chrX with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
MTCP1	chrX	155,064,034	155,071,272	NA	NA	NA	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T-ALL, 3 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the MTCP1 gene on chrX with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
MUC4	chr3	195,746,767	195,811,973	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the MUC4 gene on chr3 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
MYC	chr8	127,735,434	127,742,951	plus	Diffuse large B-cell lymphoma/ high grade B-cell lymphoma with MYC and BCL2 rearrangements, High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements, (WHO, PMID: 35732831).	Classification of B-ALL ;B-ALL with MYC rearrangement (PMID: 36422706)	Yes	No	IGH, MECOM	Translocation/rearranngement	FUS	ALL	1A for B-ALL, 2 for T-ALL	Optical Genome Mapping detected a t(3;8)(q26.2;q24.2) with a variant allele frequency of [%].	This is a recurrent abnormality resulting in a MYC::MECOM fusion associated with adverse risk category in AML (ELN, PMID: 35797463). In the context of ALL, this variant is associated with a poor prognosis (PMID: 36422706).
MYH9	chr22	36,281,277	36,388,018	NA	NA	NA	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T-ALL, 3 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the MYH9 gene on chr22 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
NOL4L	chr20	32,443,058	32,585,073	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the NOL4L gene on chr20 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
NR3C2	chr4	148,078,764	148,442,520	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the NR3C2 gene on chr4 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
NUTM1	chr15	34,343,315	34,357,737	plus	NA	B-ALL with NUTM1 rearrangement (PMID: 36422706)	No	No	ACIN1, ZNF618, BRD9, IKZF1, CUX1	Translocation/rearranngement	FUS	ALL	1A for B-ALL, 2 for T-ALL	Optical Genome Mapping detected a [Duplication/CN gain/rearrangement/translocation] mutation involving the NUTM1 gene on chr15 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant is associated with a good prognosis (PMID: 36422706).
OLIG2	chr21	33,025,908	33,029,195	NA	NA	NA	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T-ALL, 3 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the OLIG2 gene on chr21 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
OSTL	chr6	124,983,367	125,083,515	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the OSTL gene on chr6 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
PAG1	chr8	80,967,811	81,112,068	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the PAG1 gene on chr8 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
PAN3	chr13	28,138,505	28,295,338	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the PAN3 gene on chr13 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
PAR1_deletion	chrX	1,212,636	1,517,144	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the PAR1_deletion gene on chrX with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
PBX1	chr1	164,555,584	164,899,296	plus	B-lymphoblastic leukaemia/lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1, (WHO, PMID: 35732831).	NA	Yes	No	NA	Translocation/rearranngement	FUS	ALL	1A if fused with TCF3, otherwise 3A	Optical Genome Mapping detected a [Translocation/rearranngement] mutation involving the PBX1 gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
PIK3AP1	chr10	96,593,311	96,720,522	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the PIK3AP1 gene on chr10 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
POM121	chr7	72,879,364	72,948,304	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the POM121 gene on chr7 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
POM121C	chr7	75,416,785	75,486,291	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the POM121C gene on chr7 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
PTK2B	chr8	27,311,482	27,459,391	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the PTK2B gene on chr8 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
PTPRC	chr1	198,638,967	198,757,476	NA	NA	NA	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T-ALL, 3 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the PTPRC gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
RAG1	chr11	36,568,012	36,579,760	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the RAG1 gene on chr11 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
RAG2	chr11	36,591,942	36,598,279	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the RAG2 gene on chr11 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
RAP1GDS1	chr4	98,261,376	98,443,861	NA	NA	NA	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T-ALL, 3 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the RAP1GDS1 gene on chr4 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
RASSF3	chr12	64,610,512	64,697,567	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the RASSF3 gene on chr12 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
RNF213	chr17	80,260,860	80,398,781	NA	NA	NA	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T-ALL, 3 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the RNF213 gene on chr17 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
RPL10	chrX	154,398,229	154,402,339	NA	NA	NA	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T-ALL, 3 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the RPL10 gene on chrX with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
RPL5	chr1	92,832,036	92,841,924	NA	NA	NA	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T-ALL, 3 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the RPL5 gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
SERP2	chr13	44,373,841	44,397,714	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the SERP2 gene on chr13 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
SET	chr9	128,683,655	128,696,396	NA	NA	NA	Yes	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T/B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the SET gene on chr9 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
SLCO1B3	chr12	20,810,703	20,916,909	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the SLCO1B3 gene on chr12 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
SLX4IP	chr20	10,435,302	10,623,379	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the SLX4IP gene on chr20 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
SOX5	chr12	23,532,296	24,562,449	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the SOX5 gene on chr12 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
SPRED1	chr15	38,252,850	38,357,249	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the SPRED1 gene on chr15 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
STRN3	chr14	30,893,798	31,026,401	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the STRN3 gene on chr14 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
TAF15	chr17	35,809,455	35,847,242	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the TAF15 gene on chr17 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
TAL2	chr9	105,662,457	105,663,124	plus	NA	Provinsional entities of T-ALL (PMID: 36422706)	No	Yes	NA	Deletion/CN loss	LOF	ALL	1A for T-ALL, 2 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the TAL2 gene on chr9 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
TBL1XR1	chr3	177,020,753	177,197,260	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the TBL1XR1 gene on chr3 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
TCF3	chr19	1,609,291	1,652,615	minus	B-lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion, B-lymphoblastic leukaemia/lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1, (WHO, PMID: 35732831).	B-ALL with t(1;19)(q23.3;p13.3)/TCF3::PBX1 (PMID: 36422706)	Yes	No	NA	Translocation/rearranngement	FUS	ALL	1A if fused with PBX1, otherwise 3A	Optical Genome Mapping detected a [Translocation/rearranngement] mutation involving the TCF3 gene on chr19 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
TCF4	chr18	55,222,330	55,635,957	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the TCF4 gene on chr18 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
TCL1A	chr14	95,709,967	95,714,196	NA	NA	NA	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T-ALL, 3 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the TCL1A gene on chr14 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
TCL6	chr14	95,651,178	95,673,452	NA	NA	NA	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T-ALL, 3 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the TCL6 gene on chr14 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
TFG	chr3	100,709,290	100,748,967	NA	NA	NA	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T-ALL, 3 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the TFG gene on chr3 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
TLX1	chr10	101,131,300	101,137,789	plus	NA	Provinsional entities of T-ALL (PMID: 36422706)	No	Yes	NA	Deletion/CN loss	LOF	ALL	1A for T-ALL, 2 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the TLX1 gene on chr10 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
TLX3	chr5	171,309,248	171,312,139	plus	NA	Provinsional entities of T-ALL (PMID: 36422706)	No	Yes	NA	Deletion/CN loss	LOF	ALL	1A for T-ALL, 2 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the TLX3 gene on chr5 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
TNFRSF17	chr16	11,965,107	11,968,068	NA	NA	NA	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T-ALL, 3 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the TNFRSF17 gene on chr16 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
TNFRSF6	chr10	88,990,531	89,015,785	NA	NA	NA	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T-ALL, 3 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the TNFRSF6 gene on chr10 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
TOX	chr8	58,805,417	59,119,208	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the TOX gene on chr8 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
TPM4	chr19	16,067,507	16,103,003	NA	NA	NA	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T-ALL, 3 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the TPM4 gene on chr19 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
TRA	chr11	107,460,485	107,460,511	NA	NA	NA	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T-ALL, 3 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the TRA gene on chr11 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
TRA	chr14	21,621,904	22,552,132	NA	NA	NA	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T-ALL, 3 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the TRA gene on chr14 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
TRA-D	chr11	107,460,485	107,460,511	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the TRA-D gene on chr11 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
TRA-D	chr14	21,699,172	23,088,149	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the TRA-D gene on chr14 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
TRA-D	chr17	2,447,796	2,447,822	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the TRA-D gene on chr17 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
TRA-D	chr3	150,820,764	150,820,812	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the TRA-D gene on chr3 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
TRB	chr7	339,347	517,347	NA	NA	NA	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T-ALL, 3 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the TRB gene on chr7 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
TRD	chr14	22,422,546	22,466,577	NA	NA	NA	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T-ALL, 3 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the TRD gene on chr14 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
TRG	chr7	37,607,357	38,692,961	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the TRG gene on chr7 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
UBTF	chr17	44,205,033	44,221,626	minus	NA	B-ALL with UBTF::ATXN7L3/PAN3,CDX2 (“CDX2/UBTF”) (PMID: 36422706)	No	No	UBTF::ATXN7L3/PAN3,CDX2 (“CDX2/UBTF”)	Translocation/rearranngement	FUS	ALL	1A for B-ALL, 2 for T-ALL	Optical Genome Mapping detected a [Translocation/rearranngement] mutation involving the UBTF gene on chr17 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant is associated with a poor prognosis (PMID: 36422706).
VPREB1	chr22	22,244,787	22,245,514	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the VPREB1 gene on chr22 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
ZCCHC7	chr9	37,120,471	37,358,148	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the ZCCHC7 gene on chr9 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
ZEB2	chr2	144,364,364	144,521,057	minus	NA	Provisional entity: B-ALL, with mutated ZEB2 (p.H1038R)/IGH::CEBPE (PMID: 36422706)	No	No	IGH::CEBPE	Translocation/rearranngement	FUS	ALL	1A for B-ALL, 2 for T-ALL	Optical Genome Mapping detected a [Translocation/rearranngement] mutation involving the ZEB2 gene on chr2 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
ZNF384	chr12	6,666,477	6,689,572	minus	NA	Classification of B-ALL; B-ALL with ZNF384(362) rearrangement; Provisional entity: B-ALL, ZNF384 rearranged-like (PMID: 36422706)	Yes	No	EP300 (most common and good prognosis), TCF3, TAF15, CREBBP	Translocation/rearranngement	FUS	ALL	1A for B-ALL, 2 for T-ALL	Optical Genome Mapping detected a [Duplication/CN gain/rearrangement/translocation] mutation involving the ZNF384 gene on chr12 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant is associated with a variable prognosis (PMID: 36422706).
ZNF521	chr18	25,061,923	25,352,250	NA	NA	NA	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the ZNF521 gene on chr18 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
